The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

Paul Offit knows vaccines. A trained doctor, he spent 26 years working in pediatric infectious disease and studying the ...

Merck’s MRK second-largest product is Gardasil, which is a vaccine for the prevention of certain cancers caused by human ...

Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it ...

Valued at $1.25 billion, the deal expands BioNTech’s cancer drug portfolio and heads off royalty costs it could have owed ...

U.S. equities were mixed and little changed at midday as a second inflation report this week came in lower than anticipated.

Vaccine stocks are rising after the FDA announced it will consider updating COVID-19 vaccines to target the rapidly spreading LP.8.1. The FDA will require new clinical trials for annual boosters ...

Vaccine makers targeting COVID-19 to measles will come under investor scrutiny on Tuesday as a group of independent experts at the CDC are scheduled to meet for the first time to review U.S ...

Stocks of major European and U.S. vaccine companies fell after Robert F. Kennedy Jr.'s nomination as head of the HHS. Kennedy's anti-vaccine stance has raised concerns among FDA and NIH employees ...

In this article, we will discuss the 10 best vaccine stocks to buy now. If you want to explore similar stocks, you can also take a look at 5 Best Vaccine Stocks To Buy Now. The stock market is in ...